J. Lipid Res. Did you know there is a large type edition? Click here.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

A more recent version of this article appeared on February 1, 2003

Papers In Press, published online ahead of print November 4, 2002
J. Lipid Res., doi:10.1194/jlr.M200306-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M200306-JLR200v1
44/2/399    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amigo, L.
Right arrow Articles by Nervi, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amigo, L.
Right arrow Articles by Nervi, F.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on August 6, 2002
Revised on October 25, 2002
Accepted on October 30, 2002

Hepatic overexpression of sterol carrier protein 2 inhibits VLDL production and reciprocally enhances biliary lipid secretion

Ludwig Amigo, Silvana Zanlungo, Juan Francisco Miquel, Jane M. Glick, Annabelle Rodríguez, Hydeyuki Hyogo, David Cohen, Attilio Rigotti, and Flavio Nervi

Gastroenterología, Pontificia Universidad Católica de Chile, Santiago Cas114_D

Corresponding Author: fnervi{at}med.puc.cl

We examined in vivo a role for sterol carrier protein-2 (SCP-2) in the regulation of lipid secretion across the hepatic sinusoidal and canalicular membranes. Recombinant adenovirus Ad.rSCP2 was used to over express SCP-2 in livers of mice. We determined: plasma, hepatic and biliary lipid concentrations; hepatic fatty acid (FA) and cholesterol synthesis; hepatic and biliary phosphatidylcholine (PC) molecular species; and VLDL triglyceride production. In Ad.rSCP2 mice, there was marked inhibition of hepatic FA and cholesterol synthesis to < 62% of control mice. Hepatic triglyceride contents were decreased; while cholesterol and phospholipids concentrations were elevated in Ad.rSCP2 mice. In plasma of Ad.rSCP2 animals, LDL cholesterol levels were increased and HDL cholesterol concentrations were decreased. Hepatic VLDL triglyceride production fell in Ad.rSCP2 mice to 39% of control values. Biliary cholesterol, phospholipids and bile acids outputs were increased in Ad.rSCP2 mice. Biliary PC hydrophobic index increased by 100% in Ad.rSCP2. These studies indicate that SCP-2 over expression in the liver markedly inhibits lipid synthesis as well as VLDL production, and alters hepatic lipid contents. In contrast, SCP-2 increased biliary lipid secretion and the proportion of hydrophobic PC molecular species in bile. These effects suggest a key regulatory role for SCP-2 in hepatic lipid metabolism and the existence of a reciprocal relationship between the fluxes of lipids across the sinusoidal and canalicular membranes.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Lipid Res.Home page
B. P. Atshaves, A. L. McIntosh, H. R. Payne, A. M. Gallegos, K. Landrock, N. Maeda, A. B. Kier, and F. Schroeder
SCP-2/SCP-x gene ablation alters lipid raft domains in primary cultured mouse hepatocytes
J. Lipid Res., October 1, 2007; 48(10): 2193 - 2211.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
F. Basso, L. A. Freeman, C. Ko, C. Joyce, M. J. Amar, R. D. Shamburek, T. Tansey, F. Thomas, J. Wu, B. Paigen, et al.
Hepatic ABCG5/G8 overexpression reduces apoB-lipoproteins and atherosclerosis when cholesterol absorption is inhibited
J. Lipid Res., January 1, 2007; 48(1): 114 - 126.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
S. Ren, P. Hylemon, D. Marques, E. Hall, K. Redford, G. Gil, and W. M. Pandak
Effect of increasing the expression of cholesterol transporters (StAR, MLN64, and SCP-2) on bile acid synthesis
J. Lipid Res., November 1, 2004; 45(11): 2123 - 2131.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.